SEATTLE (AP) _ CTI BioPharma Corp. (CTIC) on Thursday reported a loss of $14.8 million in its third quarter.
On a per-share basis, the Seattle-based company said it had a loss of 26 cents.
The biotechnology company posted revenue of $723,000 in the period.
The company's shares closed at $1.71. A year ago, they were trading at $3.05.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTIC at https://www.zacks.com/ap/CTIC